These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2439578)
1. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study. Omata M; Uchiumi K J Hepatol; 1986; 3 Suppl 2():S65-9. PubMed ID: 2439578 [TBL] [Abstract][Full Text] [Related]
2. Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model. Takano S; Omata M; Yokosuka O; Imazeki F; Ohto M Dig Dis Sci; 1992 Nov; 37(11):1633-43. PubMed ID: 1425062 [TBL] [Abstract][Full Text] [Related]
3. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. Yokosuka O; Omata M; Imazeki F; Hirota K; Mori J; Uchiumi K; Ito Y; Okuda K Gastroenterology; 1985 Aug; 89(2):246-51. PubMed ID: 4007415 [TBL] [Abstract][Full Text] [Related]
4. Effect of adenine arabinoside and alpha-interferon in patients with HBeAg-positive chronic active hepatitis. Lee SU; Choi KH; Ha BJ; Suh SY; Han BH; Ku JY; Park BC Korean J Intern Med; 1990 Jan; 5(1):1-4. PubMed ID: 2271507 [TBL] [Abstract][Full Text] [Related]
6. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate. Hoofnagle JH J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579 [TBL] [Abstract][Full Text] [Related]
7. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. Scullard GH; Pollard RB; Smith JL; Sacks SL; Gregory PB; Robinson WS; Merigan TC J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of chronic active hepatitis caused by hepatitis B virus infection]. Degos F; Marcellin P; Benhamou JP Gastroenterol Clin Biol; 1988 Nov; 12(11):845-54. PubMed ID: 2464521 [No Abstract] [Full Text] [Related]
9. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside. Scullard GH; Andres LL; Greenberg HB; Smith JL; Sawhney VK; Neal EA; Mahal AS; Popper H; Merigan TC; Robinson WS; Gregory PB Hepatology; 1981; 1(3):228-32. PubMed ID: 6169615 [No Abstract] [Full Text] [Related]
10. A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B. Lee SD; Tong MJ; Wu JC; Lin HC; Tsai YT; Lo KJ J Hepatol; 1991 Mar; 12(2):246-50. PubMed ID: 2051004 [TBL] [Abstract][Full Text] [Related]
11. Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal. Itoh S; Matsuo S; Oda T; Marutani K; Sasaki K Dig Dis Sci; 1990 Sep; 35(9):1110-4. PubMed ID: 2390925 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV. Trépo C; Ouzan D; Fontanges T; Chevallier M; Chossegros P; Degos F; Chevallier P; Hantz O J Hepatol; 1986; 3 Suppl 2():S97-105. PubMed ID: 2439581 [TBL] [Abstract][Full Text] [Related]
13. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs. Loeschke K; Abb J; Farack UM; Wiebecke B Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200 [TBL] [Abstract][Full Text] [Related]
14. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310 [TBL] [Abstract][Full Text] [Related]
15. The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication. Perrillo RP J Hepatol; 1986; 3 Suppl 2():S57-64. PubMed ID: 2439577 [TBL] [Abstract][Full Text] [Related]
16. Short-term prednisolone followed by recombinant human alpha-interferon alone or combined with adenine-arabinoside in chronic hepatitis B. A prospective and randomized trial. Brissot P; Jacquelinet C; Jouanolle H; David V; Guyader D; Guéguen M; Blayau M; Lescoat G; Messner M; Deugnier Y J Hepatol; 1991 Mar; 12(2):181-9. PubMed ID: 2050997 [TBL] [Abstract][Full Text] [Related]
17. [Antiviral preparations in the therapy of chronic viral hepatitis]. Geller LI Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074 [TBL] [Abstract][Full Text] [Related]
18. Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy. Hirai N; Shimizu M; Morioka T; Hinoue Y; Tanaka N; Kobayashi K; Hattori N; Hashimoto T Liver; 1988 Jun; 8(3):138-45. PubMed ID: 3393063 [TBL] [Abstract][Full Text] [Related]
19. [Vidarabine-interferon combination in patients with chronic viral hepatitis B of mutant form. Efficiency and tolerability during a pilot study]. Durand M; Bost F; Maynard M; Baud M; Cohard M; Zarski JP Presse Med; 1996 Mar; 25(9):459. PubMed ID: 8685199 [No Abstract] [Full Text] [Related]
20. [Antiviral combination therapy in chronic hepatitis B]. de Man RA; Schalm SW; Heijtink RA; Chamuleau RA; Reesink HW; den Ouden J Ned Tijdschr Geneeskd; 1987 Jul; 131(28):1221-5. PubMed ID: 3614417 [No Abstract] [Full Text] [Related] [Next] [New Search]